Showing results (251-260 of 520) with videos related to
Sort By:
Pageof 52
Journal of Acquired Immune Deficiency Syndromes (1999)|May 3, 2019
Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIVRosan A van Zoest, Matthew Law, Caroline A Sabin, et al.AIDS (London, England)|November 4, 2000
The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral loadV Miller, C A Sabin, A N Phillips, et al.AIDS (London, England)|January 26, 2017
Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavirSophie Jose, Mark Nelson, Andrew Phillips, et al.Infection|January 6, 2017
Cirrhosis and liver transplantation in patients co-infected with HIV and hepatitis B or C: an observational cohort studyCharlotte Warren-Gash, Kate Childs, Alicia Thornton, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|November 13, 2014
Turner syndrome patients with bicuspid aortic valves and renal malformations exhibit abnormal expression of X-linked inhibitor of apoptosis protein (XIAP)Ganesh S Jevalikar, Margaret Zacharin, Mary White, et al.American Journal of Medical Genetics. Part A|November 22, 2017
Maternal inheritance of BDNF deletion, with phenotype of obesity and developmental delay in mother and childBrooke E Harcourt, Denise V R Bullen, Kung-Ting Kao, et al.International Journal of Cardiology|October 23, 2015
Childhood metabolic syndrome, inflammation and carotid intima-media thickness. The Aboriginal Birth Cohort StudyMarkus Juonala, Gurmeet R Singh, Belinda Davison, et al.HIV Medicine|April 19, 2003
An audit of antiretroviral treatment use in HIV-infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment useC A Sabin, F C Lampe, C Chaloner, et al.Obesity Research & Clinical Practice|May 14, 2020
Lower grip strength in youth with obesity identifies those with increased cardiometabolic riskTomi T Laitinen, Christoph Saner, Joel Nuotio, et al.AIDS (London, England)|December 4, 2004
Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapyCaroline A Sabin, Colette J Smith, Helen Gumley, et al.Pageof 52